1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
  1. Launch
  1. My Preqin
Book a demo

BioDiscovery, Inc.

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

1997

Location

El Segundo CA US

Primary Industry

Biotechnology

About

Based in the US, and founded in 1997, BioDiscovery, Inc. operates as a biotechnology company that develops genome and DNA sequencing software designed for clinical, research, and cancer treatments. In October 2021, BioNano Genomics, Inc., a portfolio company of 21Ventures, Battelle Ventures, Ben Franklin Technology Partners, Domain Associates, etc. BioDiscovery, Inc. provides a full line of modular software packages for image analysis, microarray data processing, and advanced analysis of CNV, enabling its clients to avail analysis and interpretation of genomic variants from microarray and NGS data.
Current Investors
Gund Investment Corporation, BioNano Genomics, Inc.

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.biodiscovery.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo